Prolias Technologies Acquires Commercial Stage microRNA ... Business Wire (press release) ... thyroid nodules and ARMIRA™, a molecular test to determine and monitor acute kidney rejection. NEW YORK--(BUSINESS WIRE)--Prolias Technologies, Inc., ... MDx Firm Prolias Licenses MiRNA IP from Cornell |
